Are patients with Down syndrome vulnerable to life-threatening COVID-19?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s13760-020-01373-8.pdf
Reference6 articles.
1. Löwensteyn YN, Phijffer EWEM, Simons JVL, Scheltema NM, Mazur NI, Nair H, et al. (2020) Respiratory syncytial virus-related death in children with Down syndrome: the RSV GOLD study. Pediatr Infect Dis J. https://doi.org/10.1097/INF.0000000000002666
2. Pérez-Padilla R, Fernández R, García-Sancho C, Franco-Marina F, Aburto O, López-Gatell H et al (2010) Pandemic (H1N1) 2009 virus and Down syndrome patients. Emerg Infect Dis 16(8):1312–1314
3. Zhang C, Wu Z, Li JW, Zhao H, Wang GQ (2020) The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 29:105954
4. Kusters MA, Bok VL, Bolz WE, Huijskens EG, Peeters MF, de Vries E (2012) Influenza A/H1N1 vaccination response is inadequate in down syndrome children when the latest cut-off values are used. Pediatr Infect Dis J 31(12):1284–1285
5. Lee N, Chan PK, Yu IT, Tsoi KK, Lui G, Sung JJ et al (2007) Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong Kong. J Clin Virol 40(4):333–337
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tailored vs. General COVID-19 prevention for adults with mental disabilities residing in group homes: a randomized controlled effectiveness-implementation trial;BMC Public Health;2024-06-26
2. COVID‐19 in patients with Down syndrome: A systematic review;Immunity, Inflammation and Disease;2024-03
3. Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: An integrative review;Sao Paulo Medical Journal;2024
4. Realization of Disability Equity Through Ethical Data Management Practices;Journal of the Society for Clinical Data Management;2023-11-08
5. Política de educação especial no brasil no contexto de pandemia da COVID-19;Comunicações;2023-03-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3